Cumming Ophthalmic Research and Development has filed an application for premarket approval with the U.S. Food and Drug Administration for a lens to help treat cataracts.
CORD files for premarket FDA approval for cataract treatment lens
Cumming Ophthalmic Research and Development has filed an application for premarket approval with the U.S. Food and Drug Administration for a lens to help treat cataracts.